4//SEC Filing
Cowan Chad 4
Accession 0002039294-25-000006
CIK 0001850119other
Filed
Nov 23, 7:00 PM ET
Accepted
Nov 24, 4:05 PM ET
Size
6.0 KB
Accession
0002039294-25-000006
Insider Transaction Report
Form 4
Cowan Chad
Chief Scientific Officer
Transactions
- Sale
Common Stock
2025-11-20$0.50/sh−5,462$2,736→ 987,027 total
Holdings
- 10,697(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.
- [F2]Shares held by the Cowan Investment Nominee Trust. The Reporting Person disclaims beneficial ownership except to the extent of any pecuniary interest therein, and this report shall not be deemed an admission that such shares are beneficially owned by him for Section 16 or any other purpose.
Documents
Issuer
Century Therapeutics, Inc.
CIK 0001850119
Entity typeother
Related Parties
1- filerCIK 0002039294
Filing Metadata
- Form type
- 4
- Filed
- Nov 23, 7:00 PM ET
- Accepted
- Nov 24, 4:05 PM ET
- Size
- 6.0 KB